Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments : systematic review
NAGIOS: RODERIC FUNCIONANDO

Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments : systematic review

DSpace Repository

Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments : systematic review

Show simple item record

dc.contributor.author Granate-Marques, António es
dc.contributor.author Polis Yanes, Carlos es
dc.contributor.author Seminario Amez, Maria es
dc.contributor.author Jane Salas, Enric es
dc.contributor.author López López, José es
dc.date.accessioned 2019-04-15T10:50:09Z
dc.date.available 2019-04-15T10:50:09Z
dc.date.issued 2019 es
dc.identifier.uri http://hdl.handle.net/10550/69961
dc.description.abstract The aim of this study was to determine if the treatment with bisphosphonates other anti-resorptive and antiangiogenic agents influences the success of regenerative and / or implant treatments. We reviewed the literature from the last 5 years in the PubMed database, using the following words: ?Sinus Floor Augmentation?[Mesh] OR ?Dental Implants?[Mesh]) OR ?Guided Tissue Regeneration?[Mesh]) AND ?Osteonecrosis?[Mesh]. The articles were selected following the inclusion and exclusion criteria and were evaluated using the 22 items of the STROBE declaration. The following PICO clinical question was applied: Does the treatment with agents associated with drug osteonecrosis influence the success of regenerative and implant treatments? The initial search resulted in a total of 27 articles. After eliminating those that did not refer to the topic, were duplicated or did not meet the inclusion / exclusion criteria, a full reading of the articles was made evaluating their methodological quality, obtaining six studies with high methodological quality and two with moderate. The literature regarding this topic is scarce, randomized clinical trials would be necessary to establish protocols relative to implant treatment in patients on antiresorptive treatments. The risk of developing an osteonecrosis associated with the regeneration / implant placement in patients with benign bone diseases is scarce, but it exists and it should not be underestimated. Especially, in the posterior areas of the jaw, if the duration of treatment with BP is greater than 3 years, and if the patient is under therapy with systemic corticosteroids. es
dc.source Granate-Marques, António ; Polis Yanes, Carlos ; Seminario Amez, Maria ; Jane Salas, Enric ; López López, José. Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments : systematic review. En: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, 24 2 2019: 11- es
dc.title Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments : systematic review es
dc.type info:eu-repo/semantics/article en
dc.type info:eu-repo/semantics/publishedVersion en
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.identifier.doi 10.4317/medoral.22691 es

View       (846.0Kb)

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search

Browse

Statistics